Avandia -- a diabetes drug -- may have a higher risk of hip and other fractures because the medicine decreases bone formation, according to new research by doctors in New Zealand.
The latest research comes when Avandia is being challenged by new market entrants and raises the question as to whether the drug increases the risk of osteoporosis, or brittle bone disease.
For more, go here.
